Lōvu Health, a digital platform that supports mothers and babies from the time of conception through the postpartum period, recently raised $8 million in Series A funding. This funding was led by SJF Ventures, with support from other investors such as Rogue Women’s Fund, Symphonic Capital, and Emmeline Ventures. The company is tackling a major issue in the U.S., where almost half of women skip prenatal or postnatal care because of high costs and limited access. Lōvu provides ongoing and connected maternal care, changing how women receive support before and after childbirth.
Health Technology Insights: Brook.ai Boosts HEDIS Scores for Rural Healthcare Providers
Every year, over 3.6 million babies are born in the U.S., yet despite the country spending about $126 billion on pregnancy and postpartum care, it ranks poorly in maternal mortality compared to other wealthy nations. More than 80% of these deaths could have been prevented. Lōvu is working to fix this by adding specialized care options to the plans set by obstetricians, offering real-time remote monitoring, and creating a personalized journey for each mother. Noel Pugh, co-founder and CEO of Lōvu Health, said the current approach to maternal care is too general and doesn’t meet individual needs. He explained that Lōvu’s AI platform helps healthcare providers keep a closer eye on patients and intervene early when problems arise, while also providing comprehensive support to improve outcomes.
Health Technology Insights: Livmor Launches AgentIQ: AI Medicare Platform for AEP
The need for better maternal care has become even more urgent as Medicaid and other safety-net programs face budget cuts. Lōvu’s model offers 24/7 support, access to specialty care and social services, and creates a new income stream for obstetricians without adding more work. This platform helps women with no insurance, Medicaid, or private coverage. Lōvu’s technology has been effective in identifying conditions like hypertension and mental health issues early. It has helped detect preeclampsia in 6% of mothers before traditional methods and found depression or anxiety in about 30% of patients, with 57% of chronic hypertension cases identified through its monitoring.
Dr. Santosh Pandipati, co-founder and Chief Health Officer at Lōvu, pointed out the shortcomings in the current maternal care system, especially in identifying pregnancies that need more attention. He explained that Lōvu improves the patient experience by personalizing care and quickly connecting women to top services through trusted care navigators and a specialized marketplace. The platform gives clinicians useful data to focus on prevention rather than just reacting to problems, which helps improve the health of mothers, babies, and families. With many obstetricians dealing with heavy workloads and burnout, especially in areas with few providers, Lōvu is a great support tool that eases the burden on doctors and ensures mothers get the care they need.
Lōvu gathers important data like fetal heart rate, maternal blood pressure, weight, heart rate, and mental health assessments, and displays it on a simple dashboard that alerts clinicians to any changes in a patient’s condition. The platform also connects patients to a marketplace with over 50 third-party vendors offering specialized services such as doula care, lactation consulting, sexual health counseling, pelvic floor therapy, nutrition, and mental health support. This marketplace helps doctors improve maternal outcomes and attract more patients, especially in underserved or rural areas where specialty care is hard to find. By giving mothers more control over their care, Lōvu has helped reduce wait times for mental health providers by up to four months.
Perry Clarkson, Partner at SJF Ventures, said the firm has long been interested in maternal health and sees Lōvu as a standout company because it expands obstetric care by connecting it with a network of specialty solutions. He described this approach as a win for providers, health plans, and mothers. As maternal complications and deaths are increasing, he expressed pride in supporting Lōvu’s mission to bring meaningful change to maternal healthcare in the U.S. The new funds will be used to improve the company’s AI capabilities with three new agent tools launching soon. They will also go toward automation, system integrations, and hiring more staff to handle growing demand. Lōvu is improving the maternal care experience to close existing gaps and fight preventable maternal deaths across the nation.
Health Technology Insights: EQUASHIELD Unveils CellSHIELD for Cell and Gene Therapy
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
